Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
*IPRATROPRIUM HFA 13GM INH (ATROVENT HFA) (CDM 25015705) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved June 27, 2026 , from http://ppman.hank.ai/transparency/procedure/25015705/by-state?code_type=CDM
“*IPRATROPRIUM HFA 13GM INH (ATROVENT HFA) (CDM 25015705) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/25015705/by-state?code_type=CDM. Accessed
June 27, 2026 .
“*IPRATROPRIUM HFA 13GM INH (ATROVENT HFA) (CDM 25015705) by State,” HANK Price Transparency ,
accessed June 27, 2026 ,
http://ppman.hank.ai/transparency/procedure/25015705/by-state?code_type=CDM.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
CDM · across United States
25015705 — *ipratroprium Hfa 13gm Inh (atrovent Hfa)
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$1,416
National median
$1,416 – $10,580
IQR (p25 – p75)
3
hospitals filing
1
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 25015705 (CDM), with interquartile range
State Median p25 p75
MN $1,416 $1,416 $10,580